Many leukemias can be treated successfully, but if the disease doesn’t respond, patients are left with few options. A new therapy may change all that.

Treatment for follicular lymphoma — the most common type of non-Hodgkin lymphoma — often comes with serious side effects. New research may change that for many patients.

While leukemia treatments can be uncomfortable, they also save lives. Still, reducing the discomfort of these treatments remains important, especially for the youngest patients.

Age can impact a patient’s treatment options, but when it comes to stem cell transplants, a recent study showed that being old may not be something to be worry about.

Venous thromboembolism (VTE) is rare in children, which often causes it to be overlooked, leading to delays in treatment that can sometimes be deadly.

Myelofibrosis is a type of chronic leukemia that attacks bone marrow. Researchers at Mayo Clinic showed promising study results for one treatment for this disease.

A medication taken off the market in 2010 may have a new use in treating children with an aggressive form of blood cancer.

To avoid potentially lethal complications, stem cell transplants had to use cells donated by relatives of the patient or perfectly matched donors. Not anymore. Researchers are expanding the possibilities.

Stem cell transplants that replace damaged blood cells with healthy ones can be life-saving procedures for people living with blood cancers. Advances have made stem cell transplants available to more people.

Stem cell transplants are potentially curative treatments for blood cancer patients. But a common side effect of this procedure, called graft-versus-host disease, can be very serious, even deadly.